Is BioXcel Therapeutics, Inc. technically bullish or bearish?

Sep 20 2025 08:03 PM IST
share
Share Via
As of September 9, 2025, BioXcel Therapeutics, Inc. shows a mildly bearish trend with mixed technical indicators and significant underperformance compared to the S&P 500, reflecting a year-to-date return of -49.69% versus the S&P 500's 12.22%.
As of 9 September 2025, the technical trend for BioXcel Therapeutics, Inc. has changed from sideways to mildly bearish. The weekly MACD is mildly bullish, but the monthly MACD is also mildly bullish, indicating some mixed signals. The daily moving averages are mildly bullish, while the weekly Dow Theory shows a mildly bearish stance. The Bollinger Bands present a mildly bullish signal on the weekly but bearish on the monthly, and the KST is bullish weekly but only mildly bullish monthly. The OBV is mildly bearish on the weekly timeframe.

In terms of performance, BioXcel has significantly underperformed compared to the S&P 500 across all periods, with a year-to-date return of -49.69% versus the S&P 500's 12.22%, and a one-year return of -70.48% compared to the S&P 500's 17.14%. Overall, the current technical stance is mildly bearish, driven by the mixed indicators and significant underperformance relative to the benchmark.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is BioXcel Therapeutics, Inc. overvalued or undervalued?
Sep 20 2025 06:36 PM IST
share
Share Via
Is BioXcel Therapeutics, Inc. overvalued or undervalued?
Jun 25 2025 09:17 AM IST
share
Share Via
What does BioXcel Therapeutics, Inc. do?
Jun 22 2025 07:00 PM IST
share
Share Via
How big is BioXcel Therapeutics, Inc.?
Jun 22 2025 06:13 PM IST
share
Share Via